Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Precision oncology lacks scalable tools to assess, at the patient level, systems-level tumor microenvironment (TME) programs driving therapeutic resistance. To address this gap, we trained a weakly-supervised deep learning model that uses routine H&E whole-slide images (WSIs) to derive quantitative activity for therapeutically-relevant TME phenotypes, spanning immune, metabolic, and tumor cell-int...
The opaque nature of deep learning models remains a significant barrier to their clinical adoption in medical imaging. This paper presents a multimodal explainability framework that bridges the gap between convolutional neural network (CNN) predictions and clinically actionable insights for brain tumor classification, leveraging large language models (LLMs) to deliver human-interpretable diagnosti...
We introduce a new strategy for compositional neural surrogates for radiation-matter interactions, a key task spanning domains from particle physics t...
The ABACUS study was a single arm, phase II trial evaluating neoadjuvant atezolizumab in operable urothelial carcinoma. Initial bulk transcriptomic an...
Predicting the anatomical site of metastasis from a primary tumour remains an unsolved problem in breast cancer (BRCA) and metastatic disease more bro...
Background and objective: High-risk non-muscle-invasive bladder cancer (HR-NMIBC) is treated with transurethral resection and intravesical BCG instill...
Background: Triple-negative breast cancer (TNBC) exhibits substantial molecular heterogeneity and lacks targeted receptor therapies. Single-omic appro...
Inferring tumor molecular phenotypes from high-dimensional multi-omic data is a fundamental challenge in computational biology. Current methods for es...
Mechanistic modeling has long been used as a tool to describe the dynamics of biological systems, especially cancer in response to treatment. Their ke...
Chimeric Antigen Receptor T-cell (CAR-T) therapy, where genetically engineered patient T cells target tumor antigens, has transformed care for hematol...
Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with particularly severe consequences in sub-Saha...
In biomedical scientific discovery, synthesizing prior knowledge from the literature is an essential component of interpreting numerical omics data an...
Assays coupling high-throughput lineage tracing with single-cell transcriptomics are transforming studies of development and disease biology, revealin...
The clinical integration of deep learning models for brain tumor diagnosis in neuro-oncology is severely constrained by limited expert-annotated MRI d...
A brain tumor is a medical disorder faced by individuals of all demographics. Medically, it is described as the spread of non-essential cells close to...
Chemotherapy dose optimization can be formulated as a dynamic treatment regime, requiring sequential decisions under uncertainty that must balance tum...
Predicting microsatellite instability (MSI) status from routine hematoxylin and eosin (H&E) whole slide images (WSIs) offers a practical alternative t...
Accurate histological differentiation between adenocarcinoma (ADC) and squamous cell carcinoma (SCC) is critical for personalized treatment in non-sma...
Ovarian cancer is one of the gynecological cancer types, which, if metastasized and not detected early, can cause deaths among women. Therefore, there...
T-cell receptor (TCR) repertoires encode the organization of adaptive immunity and its reshaping by cancer and therapy, but disentangling treatment-as...